These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34414376)

  • 1. Minimal Risk Level Derivation for Cadmium: Acute and Intermediate Duration Exposures.
    Faroon O; Keith S; Mumtaz M; Ruiz P
    J Exp Clin Toxicol; 2017 Nov; 1(1):1-12. PubMed ID: 34414376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of a site-specific reference dose for methylmercury for fish-eating populations.
    Shipp AM; Gentry PR; Lawrence G; Van Landingham C; Covington T; Clewell HJ; Gribben K; Crump K
    Toxicol Ind Health; 2000 Nov; 16(9-10):335-438. PubMed ID: 11762928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical risk assessment and uncertainty associated with extrapolation across exposure duration.
    Pohl HR; Chou CH; Ruiz P; Holler JS
    Regul Toxicol Pharmacol; 2010 Jun; 57(1):18-23. PubMed ID: 19944126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health effects classification and its role in the derivation of minimal risk levels: neurological effects.
    Chou CH; Williams-Johnson M
    Toxicol Ind Health; 1998; 14(3):455-71. PubMed ID: 9569449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilizing uncertainty factors in minimal risk levels derivation.
    Pohl HR; Abadin HG
    Regul Toxicol Pharmacol; 1995 Oct; 22(2):180-8. PubMed ID: 8577953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerations and procedures in the derivation of ATSDR minimal risk levels.
    Wheeler JS; Chou S
    Vaccine; 2002 May; 20 Suppl 3():S51-5. PubMed ID: 12184367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating toxicologic end points to derive minimal risk levels for hazardous substances.
    Chou CH; Williams M; Jones D; De Rosa CT
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):71-5. PubMed ID: 12018018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health effects classification and its role in the derivation of minimal risk levels: renal effects.
    Chou CH; Pohl HR
    Regul Toxicol Pharmacol; 2005 Jul; 42(2):202-8. PubMed ID: 15921839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of hematological effects in the development of minimal risk levels.
    Abadin HG; Murray HE; Wheeler JS
    Regul Toxicol Pharmacol; 1998 Aug; 28(1):61-6. PubMed ID: 9784434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health effects classification and its role in the derivation of minimal risk levels: developmental effects.
    Pohl HR; Smith-Simon C; Hicks H
    Regul Toxicol Pharmacol; 1998 Aug; 28(1):55-60. PubMed ID: 9784433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health effects classification and its role in the derivation of minimal risk levels: hepatic effects.
    Pohl HR; Chou CH
    Regul Toxicol Pharmacol; 2005 Jul; 42(2):161-71. PubMed ID: 15869832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicity Studies of Cadmium Oxide (CAS No. 1306-19-0) Administered by Inhalation to F344/N Rats and B6C3F1 Mice.
    Toxic Rep Ser; 1995 Mar; 39():1-D3. PubMed ID: 11965238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health effects classification and its role in the derivation of minimal risk levels: reproductive and endocrine effects.
    Pohl HR; Luukinen B; Holler JS
    Regul Toxicol Pharmacol; 2005 Jul; 42(2):209-17. PubMed ID: 15921838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public health guidance values for chemical mixtures: current practice and future directions.
    Pohl HR; Hansen H; Chou CH
    Regul Toxicol Pharmacol; 1997 Dec; 26(3):322-9. PubMed ID: 9441922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health effects classification and its role in the derivation of minimal risk levels: immunological effects.
    Abadin HG; Chou CH; Llados FT
    Regul Toxicol Pharmacol; 2007 Apr; 47(3):249-56. PubMed ID: 17194513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of ATSDR's MRL and EPA's RfCs/RfDs: Similarities, Differences, and Rationales.
    Przybyla J; Buser MC; Abadin HG; Pohl HR
    J Toxicol Pharmacol; 2020 Oct; 4(1):1-13. PubMed ID: 37384327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical warfare agents: estimating oral reference doses.
    Opresko DM; Young RA; Faust RA; Talmage SS; Watson AP; Ross RH; Davidson KA; King J
    Rev Environ Contam Toxicol; 1998; 156():1-183. PubMed ID: 9597943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health assessment of phosgene: approaches for derivation of reference concentration.
    Gift JS; McGaughy R; Singh DV; Sonawane B
    Regul Toxicol Pharmacol; 2008 Jun; 51(1):98-107. PubMed ID: 18440110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of Benchmark Dose of Cumulative Cadmium Exposure for Renal Tubular Effect.
    Nogawa K; Suwazono Y; Watanabe Y; Elinder CG
    Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34068156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-cancer risk assessment for nickel compounds: issues associated with dose-response modeling of inhalation and oral exposures.
    Haber LT; Allen BC; Kimmel CA
    Toxicol Sci; 1998 Jun; 43(2):213-29. PubMed ID: 9710963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.